Reflux testing products market seen reaching $4.65 billion by 2030

The reflux testing products market is projected to grow from $3.42 billion in 2025 to $4.65 billion by 2030, driven by rising GERD cases, broader use of pH monitoring and more demand for non-invasive diagnostics. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Reflux testing products are becoming more important as providers try to diagnose gastroesophageal reflux disease earlier and manage patients more precisely. - The market’s growth reflects broader demand for tools that can measure esophageal pH and impedance and help assess treatment response. - Rising Barrett’s esophagus cases add urgency because the condition increases the risk of esophageal cancer.

What happened: - The Business Research Company’s Reflux Testing Products Global Market Report 2026 projects the market will rise from $3.42 billion in 2025 to $3.62 billion in 2026. - The report forecasts the market will reach $4.65 billion by 2030. - The report was released in London on Aug. 26, 2026. - A free sample of the report is available online. - A full version of the market report is also available.

The details: - Reflux testing products include devices that measure pH levels and impedance in the esophagus. - The products help physicians detect acid reflux symptoms and understand symptom severity. - The tools also help evaluate how well proton pump inhibitors are working. - The market’s 2025-2026 growth is linked to higher GERD and acid reflux prevalence, wider availability of catheter-based testing devices, growth in gastroenterology diagnostic services, greater awareness of reflux complications and broader use of pH monitoring in clinics. - The report expects future growth to come from higher demand for non-invasive reflux diagnostics, wider use of wireless monitoring capsules, more outpatient diagnostic testing, stronger emphasis on personalized GERD management and greater integration with digital diagnostic platforms. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

Between the lines: - The forecast suggests reflux testing is shifting from a niche diagnostic category toward a broader clinical workflow tied to chronic disease management. - The emphasis on non-invasive and wireless products points to a market moving toward easier outpatient use and less burdensome patient monitoring. - The regional split suggests mature demand in North America and faster adoption potential in Asia-Pacific as diagnostic infrastructure expands.

What's next: - The market will likely be shaped by adoption of wireless capsules, outpatient testing and digital diagnostic tools over the next several years. - Providers and device makers will be watching whether personalized GERD management turns into a stronger purchasing driver. - Regional growth trends may determine where new product launches and commercial investment concentrate first.